Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2018

Open Access 01-12-2018 | Research

Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals

Authors: Anna M. Rohde, Janine Zweigner, Miriam Wiese-Posselt, Frank Schwab, Michael Behnke, Axel Kola, Birgit Obermann, Johannes K.-M. Knobloch, Susanne Feihl, Christiane Querbach, Friedemann Gebhardt, Alexander Mischnik, Vera Ihle, Wiebke Schröder, Sabina Armean, Silke Peter, Evelina Tacconelli, Axel Hamprecht, Harald Seifert, Maria J. G. T. Vehreschild, Winfried V. Kern, Petra Gastmeier, on behalf of the DZIF-ATHOS study group

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2018

Login to get access

Abstract

Background

Infections caused by third generation cephalosporin-resistant Enterobacteriaceae (3GCREB) are an increasing healthcare problem. We aim to describe the 3GCREB infection incidence and compare it to prevalence upon admission. In addition, we aim to describe infections caused by 3GCREB, which are also carbapenem resistant (CRE).

Methods

In 2014–2015, we performed prospective 3GCREB surveillance in clinically relevant patient specimens (screening specimens excluded). Infections counted as hospital-acquired (HAI) when the 3GCREB was detected after the third day following admission, otherwise as community-acquired infection (CAI).

Results

Of 578,420 hospitalized patients under surveillance, 3367 had a 3GCREB infection (0.58%). We observed a similar 3GCREB CAI and HAI incidence (0.28 and 0.31 per 100 patients, respectively). The most frequent pathogen was 3GCR E. coli, in CAI and HAI (0.15 and 0.12 per 100 patients). We observed a CRE CAI incidence of 0.006 and a HAI incidence of 0.008 per 100 patients (0.014 per 1000 patient days).

Conclusions

Comparing the known 3GCREB admission prevalence of the participating hospitals (9.5%) with the percentage of patients with a 3GCREB infection (0.58%), we conclude the prevalence of 3GCREB in university hospitals to be about 16 times higher than suggested when only patients with 3GCREB infections are considered. Moreover, we find the HAI and CAI incidence caused by CRE in Germany to be relatively low.
Literature
1.
go back to reference World Health Organization: Antimicrobial resistance: global report on surveillance. In. WHO Library Cataloguing-in-Publication Data: World Health Organisation 2014. World Health Organization: Antimicrobial resistance: global report on surveillance. In. WHO Library Cataloguing-in-Publication Data: World Health Organisation 2014.
2.
go back to reference Rottier WC, Ammerlaan HS, Bonten MJ. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother. 2012;67(6):1311–20.CrossRefPubMed Rottier WC, Ammerlaan HS, Bonten MJ. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother. 2012;67(6):1311–20.CrossRefPubMed
3.
go back to reference European Centre for Disease Prevention and Control: Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). In. Stockholm: ECDC; 2017. European Centre for Disease Prevention and Control: Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). In. Stockholm: ECDC; 2017.
4.
go back to reference Remschmidt C, Schneider S, Meyer E, Schroeren-Boersch B, Gastmeier P, Schwab F. Surveillance of antibiotic use and resistance in intensive care units (SARI). Dtsch Arztebl Int. 2017;114(50):858–65.PubMedPubMedCentral Remschmidt C, Schneider S, Meyer E, Schroeren-Boersch B, Gastmeier P, Schwab F. Surveillance of antibiotic use and resistance in intensive care units (SARI). Dtsch Arztebl Int. 2017;114(50):858–65.PubMedPubMedCentral
5.
go back to reference Leistner R, Schroder C, Geffers C, Breier AC, Gastmeier P, Behnke M. Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the surveillance of nosocomial infections (KISS). Clin Microbiol Infect. 2015;21(3):255 e251–5.CrossRef Leistner R, Schroder C, Geffers C, Breier AC, Gastmeier P, Behnke M. Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the surveillance of nosocomial infections (KISS). Clin Microbiol Infect. 2015;21(3):255 e251–5.CrossRef
6.
go back to reference Hamprecht A, Rohde AM, Behnke M, Feihl S, Gastmeier P, Gebhardt F, Kern WV, Knobloch JK, Mischnik A, Obermann B, et al. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. J Antimicrob Chemother. 2016;71(10):2957–63. https://doi.org/10.1093/jac/dkw216. Hamprecht A, Rohde AM, Behnke M, Feihl S, Gastmeier P, Gebhardt F, Kern WV, Knobloch JK, Mischnik A, Obermann B, et al. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. J Antimicrob Chemother. 2016;71(10):2957–63. https://​doi.​org/​10.​1093/​jac/​dkw216.
9.
go back to reference Federal Ministry of Justice and Consumer Protection: German Infection Protection Act, §23. In.; 2001. Federal Ministry of Justice and Consumer Protection: German Infection Protection Act, §23. In.; 2001.
10.
go back to reference Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, Harding RM, Wilson DJ, Griffiths D, Vaughan A, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis. 2017;17(4):411–21.CrossRefPubMedPubMedCentral Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, Harding RM, Wilson DJ, Griffiths D, Vaughan A, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis. 2017;17(4):411–21.CrossRefPubMedPubMedCentral
11.
go back to reference Pouwels KB, Dolk FCK, Smith DRM, Robotham JV, Smieszek T. Actual versus 'ideal' antibiotic prescribing for common conditions in English primary care. J Antimicrob Chemother. 2018;73(suppl_2):19–26.CrossRefPubMedPubMedCentral Pouwels KB, Dolk FCK, Smith DRM, Robotham JV, Smieszek T. Actual versus 'ideal' antibiotic prescribing for common conditions in English primary care. J Antimicrob Chemother. 2018;73(suppl_2):19–26.CrossRefPubMedPubMedCentral
12.
go back to reference Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S, Sharland M, Hay AD, Moore MV, Robotham JV. Potential for reducing inappropriate antibiotic prescribing in English primary care. J Antimicrob Chemother. 2018;73(suppl_2):ii36–43.CrossRefPubMedPubMedCentral Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S, Sharland M, Hay AD, Moore MV, Robotham JV. Potential for reducing inappropriate antibiotic prescribing in English primary care. J Antimicrob Chemother. 2018;73(suppl_2):ii36–43.CrossRefPubMedPubMedCentral
13.
go back to reference Zweigner J, Meyer E, Gastmeier P, Schwab F. Rate of antibiotic prescriptions in German outpatient care - are the guidelines followed or are they still exceeded? GMS Hyg Infect Control. 2018;13 Doc04. Zweigner J, Meyer E, Gastmeier P, Schwab F. Rate of antibiotic prescriptions in German outpatient care - are the guidelines followed or are they still exceeded? GMS Hyg Infect Control. 2018;13 Doc04.
14.
go back to reference Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasevic AT, Canton R, Carmeli Y, Friedrich AW, Giske CG, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153–63.CrossRefPubMed Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasevic AT, Canton R, Carmeli Y, Friedrich AW, Giske CG, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153–63.CrossRefPubMed
15.
go back to reference Trepanier P, Mallard K, Meunier D, Pike R, Brown D, Ashby JP, Donaldson H. Awad-El-Kariem FM, Balakrishnan I, Cubbon M et al: Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures. J Antimicrob Chemother. 2017;72(2):596–603.CrossRefPubMed Trepanier P, Mallard K, Meunier D, Pike R, Brown D, Ashby JP, Donaldson H. Awad-El-Kariem FM, Balakrishnan I, Cubbon M et al: Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures. J Antimicrob Chemother. 2017;72(2):596–603.CrossRefPubMed
16.
go back to reference Otter JA, Dyakova E, Bisnauthsing KN, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth JD, Goldenberg SD. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting. J Antimicrob Chemother. 2016;71(12):3556–61.CrossRefPubMedPubMedCentral Otter JA, Dyakova E, Bisnauthsing KN, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth JD, Goldenberg SD. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting. J Antimicrob Chemother. 2016;71(12):3556–61.CrossRefPubMedPubMedCentral
17.
go back to reference Kaase M, Schimanski S, Schiller R, Beyreiss B, Thurmer A, Steinmann J, Kempf VA, Hess C, Sobottka I, Fenner I, et al. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals. Int J Med Microbiol. 2016. Kaase M, Schimanski S, Schiller R, Beyreiss B, Thurmer A, Steinmann J, Kempf VA, Hess C, Sobottka I, Fenner I, et al. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals. Int J Med Microbiol. 2016.
Metadata
Title
Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals
Authors
Anna M. Rohde
Janine Zweigner
Miriam Wiese-Posselt
Frank Schwab
Michael Behnke
Axel Kola
Birgit Obermann
Johannes K.-M. Knobloch
Susanne Feihl
Christiane Querbach
Friedemann Gebhardt
Alexander Mischnik
Vera Ihle
Wiebke Schröder
Sabina Armean
Silke Peter
Evelina Tacconelli
Axel Hamprecht
Harald Seifert
Maria J. G. T. Vehreschild
Winfried V. Kern
Petra Gastmeier
on behalf of the DZIF-ATHOS study group
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2018
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-018-0452-8

Other articles of this Issue 1/2018

Antimicrobial Resistance & Infection Control 1/2018 Go to the issue